Virbac Corporation
Form 483 issued July 28, 2023 · Bridgeton, Missouri
- Inspection
- Jul 24 – Jul 28, 2023
- Observations
- 1
- Pages
- 2
- FEI number
- 1944921
In short: On July 28, 2023, FDA issued a Form 483 with 1 observation to Virbac Corporation in Bridgeton, Missouri (FEI 1944921) after an inspection that ran Jul 24 – Jul 28, 2023. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).
At a glance
1 of 1 observations on this 483 concern production.
Most cited: 21 CFR 211.113 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Appropriate written procedures, designed to prevent objectionable microorganisms in drug products not required to be sterile…
This inspection in context
Questions about this 483
What did FDA find at Virbac Corporation?
FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.
When was Virbac Corporation inspected by FDA?
The inspection ran Jul 24 – Jul 28, 2023, and the Form 483 is dated July 28, 2023.
How do I get the full Form 483 for Virbac Corporation?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.